US Stock MarketDetailed Quotes

MIRM Mirum Pharmaceuticals

Watchlist
  • 39.530
  • +0.040+0.10%
Close Jul 22 16:00 ET
  • 39.530
  • 0.0000.00%
Post 16:22 ET
1.86BMarket Cap-10569P/E (TTM)

Mirum Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mirum Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

69.22M

+119.07%
EPS(YoY)

-0.54

+32.50%
Analyst Rating

Strong Buy

Jul 8, 2024

Mirum Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 80.899M--
--2024/Q2-- / 75.303M--
May 8, 20242024/Q169.222M / 70.171M--
Feb 28, 20242023/Q469.554M / 67.861M--
Nov 2, 20232023/Q347.725M / 38.592M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 80.899M--
--2024/Q2-- / 75.303M--
May 8, 20242024/Q169.222M / 70.171M--
Feb 28, 20242023/Q469.554M / 67.861M--
Nov 2, 20232023/Q347.725M / 38.592M--

Unlock Free Earnings Estimates

Mirum Pharmaceuticals Earnings Reports

  • Mirum Pharmaceuticals | 10-Q: Quarterly report

    May 8 16:23 ET

  • Mirum Pharmaceuticals | 10-K: Annual report

    Mar 15 17:11 ET

  • Mirum Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:15 ET

  • Mirum Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 7, 2023 06:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 8, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg